Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


DTC Regs: Merck Study May Seal Fate Of "Dual Modality" Risk Presentation

Executive Summary

A Merck study could tip the argument against FDA requiring that direct-to-consumer broadcast ads present the major statement of risk information in both audio and video format

You may also be interested in...

DTC Ads: Recall Of Risks Increases When Text Accompanies Voiceover

Merck study reverses the conclusion of the firm’s earlier research and finds that the simultaneous presentation of risk information in audio and text format boosts consumer recall.

DTC Pre-Review Guidance Could Make Promotional Campaigns More Costly

PhRMA’s assistant general counsel says that FDA’s draft might increase expenses because of the need to submit final ads in advance and the potential to be asked for extensive revisions.

DTC Proposed Rule Leaves Room For Creativity In Meeting Standards

Agency says it will be flexible in assessing if risk information in consumer-focused ads are "clear, conspicuous and neutral," but proposed rule also seeks comment on whether such information should be presented simultaneously in audio and video format.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts